Rapid Technological Advancement to Drive the Automated Microbiology Market

Tue, 05 May 2020 5:01

Automated microbiology involves the application of advanced technologies in the field of microbiology that enables the delivery of accurate and quick results. The advent of automation in microbiology accelerates the productivity, reliability, and efficiency of microbial testing. Automated microbiology helps in the early detection of various infectious agents such as parasites, viruses, fungi, and bacteria, which can cause several life-threatening diseases such as rubella, Ebola, and influenza, among others.

Increased investments by the governments and leading players for the development of novel products for infectious disease diagnosis drive the market growth. For instance, in 2019, Merck partnered with India’s Food Safety and Standards Authority of India (FSSAI) to integrate automated microbiological testing in food safety. The Center for Microbiological Analysis Training (C-MAT) will offer training programs to food safety scientists in government laboratories and FSSAI-ratified private laboratories on the latest technology in microbiological testing.

Got questions about your regional growth of

Automated Microbiology Market?

Just drop us a line or call on +1 646 480 7505

The Infectious Diseases Society of America (IDSA) has developed an action plan and policy statement to promote the investment in clinical microbiology in order to increase the adoption of automated resources that provide accurate and fast test results. On July 23, 2018, Cepheid, an American diagnostic company, reduced its Xpert tests price to USD 14, used for microbial testing of a human immunodeficiency virus (HIV), viral hepatitis (HCV), and human papillomavirus (HPV).

Key Highlights

  • The automated microbiology market was valued at USD 4,494.6 million in 2019 and is projected to grow with a CAGR of 9.18% on account of rising incidences of infectious diseases and technological advancement in microbiology.
  • The reagents segment holds the largest market share owing to the repeated purchase driven by the increasing need for a new set of reagents and surging demand for microbial research activities.
  • The automated culture systems segment is projected to grow at a significant rate due to its increasing adoption in various microbiological laboratories to perform cell biology, cell signaling, and drug discovery, and protein expression.
  • The hospital laboratories segment accounted for the largest market share
  • North America dominates the market owing to the high use of advanced technology and a strong presence of leading market players.

Key Players

  • BioMerieux S.A.
  • Becton Dickinson & Company
  • Cepheid Inc.
  • Bio-Rad Laboratories, Inc.
  • QIAGEN GmbH
  • Beckman Coulter
  • Agilent Technologies, Inc.
  • Gene-Probe, Inc.
  • Affymetrix, Inc.
  • Danaher Corporation
  • Bruker Corporation
  • Hologic Inc.
  • Roche Diagnostics
  • Alere Inc.

Key Development

  • In December 2018, BioMérieux (UK) received the U.S.FDA approval for automated pathogen identification system VITEK MS

Automated Microbiology Market Segmentation

By Product

  • Instruments
  • Automated culture systems
  • Microbiology analyzers
  • Reagents

By Therapeutics

  • Respiratory infection
  • Bloodstream infections
  • Gastrointestinal infections
  • Sexually transmitted diseases
  • Urinary tract infections

By End-User

  • Hospitals laboratories
  • Diagnostic laboratories
  • Academic and research laboratories

By Region

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • The Middle East and Africa

" Crucial Insights The Report Provides:"

* Known and Unknown Adjacencies Influencing the Growth of Market

* Explorable Revenue Sources

* Customer Behaviour Analysis

* Target Partners

* Customized Geographical Data Based on Customers as well as Competitors

* Analysis of Market Size and CAGR between the Forecast Periods

View Full Report Buy This Report Now